[1] Y.T. Ngoc Nguyen, C. Duong-Dinh, H. Vu-Quang, L. T. Lan Dinh, T. Nguyen-Minh, N. Dinh Nguyen, A. Tu Nguyen, LC-ESI-QTOF-HRMS-based myxobacterial metabolite profiling for potential anti-breast cancer extracts,
J. Med. Chem. Sci.,
2023,
6, 2767–2777. [
Crossref], [
Publisher]
[2] P.A. Kalvanagh, Y.A. Kalvanagh, A new therapeutic approach based on silymarin in the treatment of breast cancer,
2023,
5, 75–85. [
Crossref], [
Publisher], [
Pdf]
[3] F. Mohajer, G.M. Ziarani, A. Badiei, New advances on modulating nanomagnetic cores as the MRI-monitored drug release in cancer,
J. Appl. Organomet. Chem.,
2021,
1, 141-145. [
Crossref], [
Google Scholar], [
Publisher]
[4] N. Yellasubbaiah, V. Velmurugan, QSAR modeling, molecular docking, and adme studies of novel 5-oxo-imidazoline derivatives as anti-breast cancer drug compounds against MCF-7 Cell Line,
J. Med. Chem. Sci.,
2023,
6, 3087–3112. [
Crossref], [
Publisher], [
Pdf]
[5] O.E. Oyeneyin, T.G. Abayomi, N. Ipinloju, E.B. Agbaffa, D.D. Akerele, O.A. Arobadade, Investigation of amino chalcone derivatives as anti-proliferative agents against MCF-7 breast cancer cell lines-DFT, molecular docking and pharmacokinetics studies,
Adv. J. Chem. Sect. A,
2021,
4, 288–299. [
Crossref], [
Google Scholar], [
Publisher]
[6] Shagufta, I. Ahmad, S. Mathew, S. Rahman, Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer,
RSC Med. Chem.,
2020,
11, 438–454. [
Crossref], [
Google Scholar], [
Publisher]
[7] X. Lu, Y. Teng, X. Lin, M. Xiao, C. Liu, X. Chi, Y. Zhang, G. Luo, H. Xiang, Discovery of novel 2H-chromene-3-carbonyl derivatives as selective estrogen receptor degraders (SERDs): Design, synthesis and biological evaluation,
Bioorg. Chem.,
2021,
109, 104714. [
Crossref], [
Google Scholar], [
Publisher]
[8] Siswandono, R. Widyowati, A. Suryadi, T. Widiandani, D. Prismawa, Molecular modeling, synthesis, and qsar of 5-O-acylpinostrobin derivatives as promising analgesic agent,
Rasayan J. Chem.,
2020,
13, 2559–2568. [
Crossref], [
Google Scholar], [
Publisher]
[9] M.R.F. Pratama, H. Poerwono, S. Siswandono, Design and molecular docking of novel 5-O-Benzoylpinostrobin derivatives as anti-breast cancer,
Thai J. Pharm. Sci., 2019,
43, 201–212. [
Crossref], [
Google Scholar], [
Publisher]
[10] S. Asirvatham, E. Thakor, H. Jain, Morpholine and Thiomorpholine: A Privileged Scaffold Possessing Diverse Bioactivity Profile, J
. Chem. Rev.,
2021,
3, 247-272. [
Crossref], [
Google Scholar], [
Publisher]
[11] O. Babafakruddin, H. Abdul Ahad, H. Chinthaginjala, K. Tarun, G.A. Kumar, G.G. Reddy, The Design of Soft Drugs: Basic Principles, Energetic Metabolite Methods, Approved Compounds, and Pharmaceutical Applications,
J. Chem. Rev.,
2022,
4, 241-254. [
Crossref], [
Publisher]
[12] Y. Ahmadyousefi, Bacteria-Derived Chemotherapeutic Agents for Cancer Therapy: A Brief Overview,
Asian J. Green Chem.,
2023,
7, 223–228. [
Crossref], [
Pdf], [
Publisher]
[13] E.N. Praditapuspa, S. Siswandono, T. Widiandani, In silico analysis of pinostrobin derivatives from boesenbergia pandurata on ErbB4 kinase target and QSPR linear models to predict drug clearance for searching anti-breast cancer drug candidates,
Pharmacogn. J., 2021,
13, 1143–1149. [
Crossref], [
Google Scholar], [
Publisher]
[14] S. Siswandono, Kimia Medisinal Edisi ke-1. Airlangga University Press; Surabaya,
2016. [
Publisher]
[15] Lionta, G. Spyrou, D. Vassilatis, Z. Cournia, Structure-based virtual screening for drug discovery: principles, applications and recent advances,
Curr. Top. Med. Chem.,
2021,
14, 1923–1938. [
Crossref], [
Google Scholar], [
Publisher]
[16] P.A. Kalvanagh, Y.A. Kalvanagh, A new therapeutic approach based on silymarin in the treatment of breast cancer,
Adv. J. Chem. Sect. B,
2023,
5, 75–85. [
Crossref], [
Publisher]
[17] D.N. Illian, A.P. Widiyana, A.R. Hasana, H.A.I. Maysarah, S.S. Mustaniroh, M. Basyuni, In silico approach: prediction of ADMET, molecular docking, and QSPR of secondary metabolites in mangroves,
J. Appl. Pharm. Sci., 2022,
12, 21–29. [
Crossref], [
Google Scholar], [
Publisher]
[18] S. Sharma, A short review of past, present, and future of metallocene and its derivatives as an effective therapeutic agent,
J. Appl. Organomet. Chem.,
2023,
3, 142-155. [
Crossref], [
Publisher]
[19] A.B. Mezoughi, W. Abdussalam-Mohammed, A.A.A. Abdusalam, Synthesis and molecular docking studies of some thiohydantoin derivatives as potential anticancer and antimicrobial agents,
Adv. J. Chem. Sect. A,
2021,
4, 327–338. [
Crossref], [
Google Scholar], [
Publisher]
[20] M.T. Ibrahim, A. Uzairu, Structure-based identification of some potential epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) with in-silico assessment of their pharmacokinetic features and qantum cemical calculations,
Adv. J. Chem. Sect. A.,
2022,
5, 333–334. [
Crossref], [
Publisher]
[21] L. Frye, S. Bhat, K. Akinsanya, R. Abel, From computer-aided drug discovery to computer-driven drug discovery,
Drug Discov. Today: Technol.,
2021,
39, 111–117. [
Crossref], [
Google Scholar], [
Publisher]
[22] L.G. Ferreira, R.N. Dos Santos, G. Oliva, A.D. Andricopulo, Molecular docking and structure-based drug design strategies,
Molecules.,
2015,
20, 13384-13421. [
Crossref], [
Google Scholar], [
Publisher]
[23] N.K. Patel, G. Jaiswal, K.K. Bhutani, A review on biological sources, chemistry and pharmacological activities of pinostrobin,
Nat. Prod. Res.,
2016,
30, 2017–2027. [
Crossref], [
Google Scholar], [
Publisher]
[24] S. Dara, S. Dhamercherla, S.S. Jadav, C.M. Babu, M.J. Ahsan, Machine learning in drug discovery: a review.
Artif. Intell. Rev., 2021, 55, 1947-1999. [
Crossref], [
Google Scholar], [
Publisher]
[25] S. Kar, J. Leszczynski, Open access in silico tools to predict the ADMET profiling of drug candidates,
Expert. Opin. Drug. Discov., 2020,
15, 1473–1487. [
Crossref], [
Google Scholar], [
Publisher]
[26] A.S. Wiyono, Siswandono, N.W. Diyah, Molecular docking of 5-o-benzoylpinostrobin derivatives from Boesenbergia pandurata roxb. as anti-inflammatory,
J. Public Health Africa,
2023,
14. [
Crossref], [
Google Scholar], [
Publisher]
[27] S.L. Agustin, T. Widiandani, S. Hardjono, B.T. Purwanto, QSAR of acyl pinostrobin derivatives as anti-breast cancer against HER-2 receptor and their ADMET properties based on in silico Study,
RJPT, 2022,
15, 4641-4648. [
Crossref], [
Google Scholar], [
Publisher]
[28] Y. Liu, X. Yu, J. Chen, Quantitative structure–property relationship of distribution coefficients of organic compounds,
SAR QSAR Environ. Res., 2020,
31, 585–596. [
Crossref], [
Google Scholar], [
Publisher]
[29] S.H. Abdullahi, A. Uzairu, G.A. Shallangwa, S. Uba, Pharmacokinetics studies of some diaryl pyrimidinamine derivatives as anti-cancer agent : in-silico drug design and molecular docking,
Adv. J. Chem. Sect. A,
2022,
5, 320–332. [
Crossref], [
Google Scholar], [
Publisher]
[30] A.M. Hantosha, N.A. Rajab, F.T. Abachic, Synthesis, in silico ADMET, docking, antioxidant, antibacterial and antifungal evaluations of some pyrimidine derivatives,
Eurasian Chem. Commun.,
2023,
5, 216–227. [
Crossref], [
Publisher]
[31] A.B. Umar, Exploration of aticancer potential of novel pyrrolo [2,3-b] pyridine derivatives targeting V600E-BRAF kinase : molecular docking , Pharmacokinetic and DFT Studies,
Adv. J. Chem. Sect. A, 2022,
5, 271–286. [
Crossref], [
Publisher]
[32] M. Yusuf, U. Chawla, N.H. Ansari, M. Sharma, Perspective on metal-ligand coordination complexes and improvement of current drugs for neurodegenerative diseases ( NDDs ),
Adv. J. Chem. Sect. A, 2023,
6, 31–49. [
Crossref], [
Google Scholar], [
Publisher]